Recent Developments in Metal-Based Drugs and Chelating Agents for Neurodegenerative Diseases Treatments.

Interestingly, the modification of these intracellular pathways through enzymatic inhibition is quite significant in the sense of getting a good comprehension of the pathogenesis of specific neuropsychiatric and neurodegenerative disorders [ 112 ].

also in 5,695 other papers